| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.26 | 8e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |